Volgen
timens w
timens w
Onbekend partnerschap
Geen geverifieerd e-mailadres
Titel
Geciteerd door
Geciteerd door
Jaar
WHO classification of tumours of haematopoietic and lymphoid tissues
E Campo, NL Harris, ES Jaffe, SA Pileri, H Stein, J Thiele, JW Vardiman
International agency for research on cancer 2, 439, 2008
23274*2008
Pathology and genetics of tumours of haematopoietic and lymphoid tissues
ES Jaffe
Iarc, 2001
35782001
Molecular diagnosis of Burkitt's lymphoma
SS Dave, K Fu, GW Wright, LT Lam, P Kluin, EJ Boerma, TC Greiner, ...
New England Journal of Medicine 354 (23), 2431-2442, 2006
10502006
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
R Schmitz, RM Young, M Ceribelli, S Jhavar, W Xiao, M Zhang, G Wright, ...
Nature 490 (7418), 116-120, 2012
9602012
Double-hit B-cell lymphomas
SM Aukema, R Siebert, ED Schuuring, GW van Imhoff, ...
Blood, The Journal of the American Society of Hematology 117 (8), 2319-2331, 2011
8702011
Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
MHH Kramer, J Hermans, E Wijburg, K Philippo, E Geelen, J Van Krieken, ...
Blood, The Journal of the American Society of Hematology 92 (9), 3152-3162, 1998
6441998
Lymphoma-associated translocation t (14; 18) in blood B cells of normal individuals
J Limpens, R Stad, C Vos, C de Vlaam, D de Jong, GJ Van Ommen, ...
5041995
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network
M Tiemann, C Schrader, W Klapper, MH Dreyling, E Campo, A Norton, ...
British journal of haematology 131 (1), 29-38, 2005
4232005
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
J Limpens, D De Jong, JH Van Krieken, CG Price, BD Young, ...
Oncogene 6 (12), 2271-2276, 1991
3631991
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
PAS Evans, C Pott, P Groenen, G Salles, F Davi, F Berger, JF Garcia, ...
Leukemia 21 (2), 207-214, 2007
3552007
Involvement of the CCND1 gene in hairy cell leukemia
CJ De Boer, JC Kluin-Nelemans, E Dreef, MGD Kester, PM Kluin, ...
Annals of oncology 7 (3), 251-255, 1996
3401996
Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and …
NJ Senff, JJ Hoefnagel, PM Jansen, MH Vermeer, J van Baarlen, ...
Journal of clinical oncology 25 (12), 1581-1587, 2007
3302007
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
AM Glas, MJ Kersten, LJMJ Delahaye, AT Witteveen, RE Kibbelaar, ...
Blood 105 (1), 301-307, 2005
2952005
Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma
D de Jong, BMH Voetdijk, GC Beverstock, GJB van Ommen, R Willemze, ...
New England Journal of Medicine 318 (21), 1373-1378, 1988
2921988
Reduction of synovial inflammation after anti‐CD4 monoclonal antibody treatment in early rheumatoid arthritis
PP Tak, PA Van Der Lubbe, A Cauli, MR Daha, TJM Smeets, PM Kluin, ...
Arthritis & Rheumatism 38 (10), 1457-1465, 1995
2721995
Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge
EG Boerma, R Siebert, PM Kluin, M Baudis
Leukemia 23 (2), 225-234, 2009
2622009
Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.
MH Kramer, J Hermans, J Parker, AD Krol, JC Kluin-Nelemans, HL Haak, ...
Journal of Clinical Oncology 14 (7), 2131-2138, 1996
2611996
Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites
SA Riemersma, ES Jordanova, RFJ Schop, K Philippo, LHJ Looijenga, ...
Blood, The Journal of the American Society of Hematology 96 (10), 3569-3577, 2000
2382000
Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.
HH van Ravenswaay Claasen, PM Kluin, GJ Fleuren
Laboratory investigation; a journal of technical methods and pathology 67 (2 …, 1992
2351992
Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.
HH van Ravenswaay Claasen, PM Kluin, GJ Fleuren
Laboratory investigation; a journal of technical methods and pathology 67 (2 …, 1992
2351992
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20